Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
IPF
Sort By
Newest First
1 / 1
Mediar Therapeutics
Agreement
Mediar Therapeutics and Lilly Sign Global Licensing Agreement to Advance WISP1 Antibody to Treat Idiopathic Pulmonary Fibrosis
Mediar Therapeutics
PR-01-25-NI-06
Jan 10, 2025
1 / 1
